​

Avadel Pharmaceuticals (AVDL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AVDL Stock Forecast

Avadel Pharmaceuticals (AVDL) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $20.20, with a high of $22.50 and a low of $18.50. This represents a -6.22% decline from the last price of $21.54.

$10 $13 $16 $19 $22 $25 High: $22.5 Avg: $20.2 Low: $18.5 Last Closed Price: $21.54

AVDL Stock Rating

Avadel Pharmaceuticals stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (57.14%), 6 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 6 8 Strong Sell Sell Hold Buy Strong Buy

AVDL Price Target Upside V Benchmarks

TypeNameUpside
StockAvadel Pharmaceuticals-6.22%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks17.90%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$22.50$19.50
Last Closing Price$21.54$21.54$21.54
Upside/Downside-4.46%-9.47%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26--10--10
Dec, 25--10--10
Nov, 25--10--10
Oct, 25361--10
Sep, 2535---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 20, 2025Wells Fargo$22.50$23.02-2.26%4.46%
Oct 28, 2025Ashwani VermaUBS$20.00$18.567.76%-7.15%
Oct 23, 2025H.C. Wainwright$20.00$18.537.93%-7.15%
Oct 23, 2025Market PerformLeerink Partners$18.50$18.53-0.16%-14.11%
Oct 22, 2025Andrew TsaiJefferies$20.00$18.557.82%-7.15%
Sep 02, 2025Benjamin BurnettWells Fargo$16.00$14.986.81%-25.72%
Jan 10, 2025Oren LivnatH.C. Wainwright$21.00$7.90165.82%-2.51%
Jan 09, 2025Ami FadiaNeedham$19.00$10.8674.95%-11.79%
Oct 31, 2024Francois BriseboisOppenheimer$30.00$12.91132.38%39.28%
May 09, 2024Oren LivnatH.C. Wainwright$27.00$16.2566.15%25.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2025UBSNeutraldowngrade
Oct 23, 2025H.C. WainwrightBuyNeutraldowngrade
Oct 22, 2025JefferiesBuyHolddowngrade
Oct 22, 2025NeedhamBuyHolddowngrade
Aug 08, 2025Deutsche BankBuyBuyhold
Aug 08, 2025H.C. WainwrightBuyBuyhold
Jan 10, 2025OppenheimerOutperformOutperformhold
Jan 10, 2025H.C. WainwrightBuyBuyhold
Jan 09, 2025NeedhamBuyBuyhold
Oct 31, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.00$-0.51----
Avg Forecast$-1.79$-0.50$0.15$0.76$1.45$1.87
High Forecast$-1.76$-0.45$0.49$1.03$1.95$1.91
Low Forecast$-1.83$-0.53$0.03$0.49$1.27$1.81
Surprise %11.73%2.00%----

Revenue Forecast

$0 $100M $200M $300M $400M $500M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$27.96M$169.12M----
Avg Forecast$26.75M$168.79M$252.17M$336.16M$406.73M$463.03M
High Forecast$28.37M$169.03M$255.17M$338.14M$408.60M$469.81M
Low Forecast$24.11M$168.73M$247.31M$334.19M$404.86M$451.77M
Surprise %4.55%0.19%----

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-160.28M$-48.83M----
Avg Forecast$-144.15M$-39.30M$11.63M$78.12M$149.10M$149.93M
High Forecast$-141.24M$-36.16M$39.36M$82.27M$156.07M$152.78M
Low Forecast$-147.06M$-42.44M$2.19M$39.56M$101.92M$145.19M
Surprise %11.19%24.25%----

AVDL Forecast FAQ

Is Avadel Pharmaceuticals stock a buy?

Avadel Pharmaceuticals stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Avadel Pharmaceuticals is a favorable investment for most analysts.

What is Avadel Pharmaceuticals's price target?

Avadel Pharmaceuticals's price target, set by 14 Wall Street analysts, averages $20.2 over the next 12 months. The price target range spans from $18.5 at the low end to $22.5 at the high end, suggesting a potential -6.22% change from the previous closing price of $21.54.

How does Avadel Pharmaceuticals stock forecast compare to its benchmarks?

Avadel Pharmaceuticals's stock forecast shows a -6.22% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (17.90%).

What is the breakdown of analyst ratings for Avadel Pharmaceuticals over the past three months?

  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Avadel Pharmaceuticals’s EPS forecast?

Avadel Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.15, marking a -129.41% decrease from the reported $-0.51 in 2024. Estimates for the following years are $0.76 in 2026, $1.45 in 2027, and $1.87 in 2028.

What is Avadel Pharmaceuticals’s revenue forecast?

Avadel Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $252.17M, reflecting a 49.11% increase from the reported $169.12M in 2024. The forecast for 2026 is $336.16M, followed by $406.73M for 2027, and $463.03M for 2028.

What is Avadel Pharmaceuticals’s net income forecast?

Avadel Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $11.64M, representing a -123.83% decrease from the reported $-48.832M in 2024. Projections indicate $78.12M in 2026, $149.1M in 2027, and $149.93M in 2028.